JPMorgan Chase & Co’s Kite Pharma, Inc. KITE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q4 | – | Sell |
-1,528,805
| Closed | -$275M | – | 4849 |
|
2017
Q3 | $275M | Sell |
1,528,805
-838,947
| -35% | -$151M | 0.06% | 310 |
|
2017
Q2 | $245M | Sell |
2,367,752
-56,813
| -2% | -$5.89M | 0.06% | 323 |
|
2017
Q1 | $190M | Sell |
2,424,565
-570,282
| -19% | -$44.8M | 0.04% | 387 |
|
2016
Q4 | $134M | Buy |
2,994,847
+386,871
| +15% | +$17.3M | 0.03% | 454 |
|
2016
Q3 | $146M | Sell |
2,607,976
-560,080
| -18% | -$31.3M | 0.04% | 424 |
|
2016
Q2 | $158M | Buy |
3,168,056
+379,661
| +14% | +$19M | 0.04% | 401 |
|
2016
Q1 | $128M | Buy |
2,788,395
+528,222
| +23% | +$24.3M | 0.03% | 448 |
|
2015
Q4 | $139M | Buy |
2,260,173
+730,793
| +48% | +$45M | 0.04% | 446 |
|
2015
Q3 | $85.2M | Sell |
1,529,380
-160,262
| -9% | -$8.92M | 0.02% | 557 |
|
2015
Q2 | $103M | Buy |
1,689,642
+458,209
| +37% | +$27.9M | 0.02% | 553 |
|
2015
Q1 | $71M | Buy |
1,231,433
+404,867
| +49% | +$23.4M | 0.02% | 710 |
|
2014
Q4 | $47.7M | Buy |
826,566
+74,940
| +10% | +$4.32M | 0.01% | 861 |
|
2014
Q3 | $21.4M | Buy |
+751,626
| New | +$21.4M | 0.01% | 1236 |
|